BY PHILIP MADSEN
-
AbbVie strikes deal with Trump, pledges USD 100bn investment over 10 years
The arrangement is the most up to date in a collection of political campaigns targeted at decreasing medicine rates in the USA
-
AbbVie strikes deal with Trump, pledges USD 100bn investment over 10 years
The agreement is the latest in a series of political initiatives aimed at reducing drug prices in the United States
-
FDA postpones evaluation of drugs in new voucher program
A brand-new coupon program from the FDA was expected to accelerate the authorization procedure, yet numerous of the chosen medicines are currently being postponed.
-
U-turn in US health insurance gives Coloplast a “dull Christmas present”
Wellness authorities in the United States have actually rescinded a current choice that provided 2 of Coloplast’s injury treatment items unique condition with United States h…
-
Novo Nordisk ventures into uncharted territory with Wegovy pill: “We have never launched in this way before”
The upcoming launch of the Wegovy tablet computer will certainly concentrate on customers, which is totally various from what Novo Nordisk has actually been made use of to, states …
-
Novo Nordisk ventures into uncharted territory with Wegovy pill: “We have never launched in this way before”
The upcoming launch of the Wegovy tablet will focus on consumers, which is completely different from what Novo Nordisk has been used to, says Novo investor and the company’s US CEO…
-
Coloplast acquisition receives important boost from US health insurance company
Coloplast has actually gotten last verification that the firm will certainly get aids for 2 of its injury treatment items in the United States. Nonetheless, it is not all excellent…
-
Coloplast CEO on management change: “We couldn’t wait”
The following chief executive officer of Coloplast can not anticipate to create its very own group, according to the acting chief executive officer of Coloplast, that has actually …
-
Samsung reveals Exynos 2600: world’s first 2nm smartphone chip could supercharge Galaxy S26
The Exynos 2600, manufactured by Samsung Foundry, features a 10-core configuration based on Arm’s v9.3 architecture. It uses the new C1-Ultra (prime) and C1-Pro (middle) core…
-
Medline completes largest IPO of the year
With the securities market listing, the United States clinical tool firm is valued at USD 39bn.
